The aim of this study is to identify persistent symptoms in unvaccinated community-managed patients following COVID-19 infection.
A man aged 60 years presented with an irregularly shaped erythematous scalp plaque with a 5 cm diameter.
Growing evidence shows that lifestyle interventions are an effective component of management for patients with mental illness to improve mental health, physical health and quality of life.
There is a need to enhance aged care exposure for general practice registrars in ways that build on the competence of registrars and the trust in registrars by older patients and supervisors.
General practitioners are well positioned to take a comprehensive approach to the management of functional decline in older people, aided by a range of funded programs.
Young people experience higher rates of sexually transmissible infections and lower screening rates than the general population in Australia.
Medicare Benefits Schedule rules regarding sleep study eligibility have recently changed and incorporate validated questionnaires of obstructive sleep apnoea risk and subjective sleepiness.
MND is a group of neurodegenerative disorders best managed using a multidisciplinary approach, with the general practitioner as an integral part of the team.
Botulinum neurotoxin is an effective treatment for various movement disorders that are disabling and frequently under-recognised.
A male aged 16 years presented to the emergency department with a three-day history of oral ulceration involving the lips that was associated with skin and genital lesions.
Medicinal cannabis is generally well tolerated, but the science related to its potential adverse effects is in its infancy.
The enhanced Residential Medication Management Review program will address barriers and support general practitioners to make medication changes for older Australians.
Although not all women undergoing mastectomy will desire or choose breast reconstruction, it is important that all women have the opportunity to make an informed choice.
Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.
An updated overview of Burkholderia pseudomallei, the causative agent of melioidosis, including epidemiology, risk factors for infection, spectrum of clinical disease, diagnosis and management.